Treatment of ITP With Rituximab and / or Accutane

NCT02757196 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Rituximab plus methylprednisolone
DRUG: methylprednisolone

Sponsor

Peking University People's Hospital

Collaborators

[object Object]